Impact of diabetes mellitus on the pharmacodynamic effects of ticagrelor versus clopidogrel in troponin-negative acute coronary syndrome patients undergoing ad-hoc percutaneous coronary intervention
The platelet protease-activated receptor-4 antagonist, UDM-002555, alone and in combination with aspirin inhibits arterial thrombosis with limited impact on hemostasis in cynomolgus monkeys
Can off-pump coronary artery bypass graft surgery be performed 3 days after clopidogrel discontinuation without increasing the bleeding risk in acute coronary syndrome patients?
Large mean platelet volume is associated with impaired clopidogrel-responsiveness in acute coronary syndrome patients, with no impact on prasugrel or ticagrelor effects
Speaker:
Doctor A. Marcano Fernandez (L'hospitalet De Llobregat, ES)